Analysis Article • Jun 05
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedJul 21, 2026
DataAggregated Company Financials
Companies47
- 7D-0.8%
- 3M6.6%
- 1Y3.2%
- YTD2.4%
Over the last 7 days, the Healthcare industry has dropped 1.2%, driven by a pullback from Diagnostyka of 3.7%. On the other hand NEUCA is actually up 6.1%. Over the last year, the industry has been flat overall. Earnings are forecast to be flat in the coming years.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jul 2026 | zł21.4b | zł20.6b | zł702.6m | 19.1x | 30.4x | 1x |
| Thu, 18 Jun 2026 | zł20.5b | zł20.6b | zł313.3m | 20.6x | 65.3x | 1x |
| Sat, 16 May 2026 | zł19.6b | zł20.2b | zł246.6m | 20.5x | 79.6x | 1x |
| Mon, 13 Apr 2026 | zł19.4b | zł20.0b | zł283.7m | 19.8x | 68.4x | 1x |
| Wed, 11 Mar 2026 | zł20.5b | zł19.8b | zł414.4m | 22.2x | 49.4x | 1x |
| Fri, 06 Feb 2026 | zł20.7b | zł19.8b | zł399.5m | 20.7x | 51.9x | 1x |
| Sun, 04 Jan 2026 | zł20.1b | zł19.8b | zł399.5m | 19.5x | 50.3x | 1x |
| Tue, 02 Dec 2025 | zł20.6b | zł19.7b | zł359.6m | 22.2x | 57.3x | 1x |
| Thu, 30 Oct 2025 | zł20.3b | zł19.2b | zł353.2m | 24.3x | 57.5x | 1.1x |
| Sat, 27 Sep 2025 | zł21.0b | zł19.2b | zł380.2m | 23.1x | 55.2x | 1.1x |
| Mon, 25 Aug 2025 | zł20.7b | zł18.8b | zł391.2m | 21.1x | 52.9x | 1.1x |
| Wed, 23 Jul 2025 | zł19.6b | zł18.8b | zł375.7m | 20.8x | 52.3x | 1x |
| Fri, 20 Jun 2025 | zł19.1b | zł17.6b | zł154.5m | 20.8x | 123.7x | 1.1x |
| Sun, 18 May 2025 | zł20.5b | zł17.3b | zł237.5m | 23.1x | 86.3x | 1.2x |
| Tue, 15 Apr 2025 | zł18.6b | zł17.1b | zł97.8m | 29.8x | 190.4x | 1.1x |
| Thu, 13 Mar 2025 | zł19.1b | zł16.6b | zł123.9m | 30x | 153.9x | 1.1x |
| Sat, 08 Feb 2025 | zł17.7b | zł16.6b | zł113.3m | 23.8x | 155.8x | 1.1x |
| Mon, 06 Jan 2025 | zł15.3b | zł16.7b | zł123.0m | 24.2x | 124.4x | 0.9x |
| Wed, 04 Dec 2024 | zł14.9b | zł16.7b | zł117.6m | 22.4x | 126.6x | 0.9x |
| Fri, 01 Nov 2024 | zł15.2b | zł16.4b | zł55.1m | 22.7x | 276.3x | 0.9x |
| Sun, 29 Sep 2024 | zł15.5b | zł16.4b | zł131.8m | 28.3x | 117.3x | 0.9x |
| Tue, 27 Aug 2024 | zł15.7b | zł16.2b | zł140.2m | 29.5x | 111.7x | 1x |
| Thu, 25 Jul 2024 | zł15.1b | zł16.2b | zł133.8m | 29.3x | 113.1x | 0.9x |
| Sat, 22 Jun 2024 | zł14.6b | zł16.2b | zł102.5m | 26.2x | 142x | 0.9x |
| Mon, 20 May 2024 | zł15.2b | zł16.0b | zł81.0m | 23.5x | 187.4x | 0.9x |
| Wed, 17 Apr 2024 | zł14.9b | zł16.0b | -zł100,002,749.00 | 38.7x | -148.9x | 0.9x |
| Fri, 15 Mar 2024 | zł15.1b | zł16.0b | -zł218,743,549.00 | 40.8x | -69.3x | 0.9x |
| Sun, 11 Feb 2024 | zł14.6b | zł15.9b | -zł257,176,129.00 | 36.5x | -56.7x | 0.9x |
| Tue, 09 Jan 2024 | zł14.9b | zł15.9b | -zł245,263,080.00 | 32.2x | -60.6x | 0.9x |
| Thu, 07 Dec 2023 | zł14.4b | zł15.9b | zł94.7m | 29.2x | 152.4x | 0.9x |
| Sat, 04 Nov 2023 | zł13.4b | zł15.7b | zł110.2m | 31.1x | 121.4x | 0.9x |
| Mon, 02 Oct 2023 | zł13.5b | zł15.7b | zł94.0m | 27.4x | 143.4x | 0.9x |
| Wed, 30 Aug 2023 | zł14.3b | zł15.5b | zł103.2m | 22.7x | 138.2x | 0.9x |
| Fri, 28 Jul 2023 | zł14.3b | zł15.4b | zł101.1m | 25.1x | 141.3x | 0.9x |
Price to Earnings Ratio
141.3x
Current Industry PE
- Investors are pessimistic on the Polish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 30.3x which is lower than its 3-year average PE of 86.4x.
- The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 91% per year over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | -0.51% | |
| Healthcare | -0.78% | |
| Pharma | 6.48% | |
| Biotech | 2.07% | |
| Healthcare Services | -0.22% | |
| Healthtech | -2.33% | |
| Medical Equipment | -4.00% | |
| Life Sciences | -6.91% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 28.2x.
- Analysts are expecting annual earnings growth of 11.2%, which is higher than its past year's earnings growth of 4.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 58% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Pharma industry is expected to see its earnings decline by 140% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NEU NEUCA | zł743.00 | 6.1% +zł198.7m | 10.1% | PE19.1x | |
| CLN Celon Pharma | zł21.00 | 7.6% +zł79.7m | -12.5% | PE10.4x | |
| PTG Poltreg | zł24.20 | 27.4% +zł30.8m | -24.4% | PB3.9x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł75.40 | 2.6% +zł12.1m | 85.7% | PS201.1x | |
| MAB Mabion | zł7.74 | 6.0% +zł7.1m | -18.3% | PS7.1x |